Finzati - Logo
XAGE logo

Longevity Health Holdings Inc.

XAGEBiotechnology
$0.21
-0.01 (-5.83%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$398,981.1
Growth
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 46034.2%Weak liquidity · 0.25Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 14, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:25 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.21
Change-5.83%
Shares Out1.90M
Market Cap$398.98K
Enterprise Value$298.04K
52W Range0.21 - 2.85
Beta0.40
P/E-0.06
P/S0.22
P/B-0.06
P/FCF-0.13
EV/Sales0.17

Investment DNA

How strong this company looks for long-term investors

49
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score
Positive revenue growth · 46034.2%Weak liquidity · 0.25Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 9/23/2021
Industry: Biotechnology
P/B i: -0.06
Debt / Equity i: -0.09
Operating Margin: -371.58%
Net Margin: -361.00%
ROE i: -
ROIC: -

Financial Health

Score4 / 20
Debt / Equity: -0.09
Current Ratio: 0.25
Quick Ratio: 0.12
Status: HighRisk

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Ajjarapu J. Ram
Transaction: 03/16/2026
OTHER
Change
0
Price
Not reported
Filing
04/08/2026
Type
OTHER
Frisch Scott M.
Transaction: 10/11/2024
BUY
Change
+76,878
Price
$0.36
Filing
11/08/2024
Type
BUY
Shukla Rajiv
Transaction: 10/11/2024
BUY
Change
+876,878
Price
$0.36
Filing
11/08/2024
Type
BUY